Search research articles
Contact Us
Filters
Showing results (101-110 of 128) with videos related to
Page
of 13
Sort By:
Journal of Neuroimmunology
|
December 4, 2014
Therapeutic targets in subependymoma
Ling-Yuan Kong, Jun Wei, Ali S Haider, et al.
Biochimica Et Biophysica Acta
|
March 26, 2013
Development of novel molecular probes of the Rio1 atypical protein kinase
Marcin Mielecki, Krzysztof Krawiec, Irene Kiburu, et al.
Biomedicines
|
October 26, 2024
Potent Biological Activity of Fluorinated Derivatives of 2-Deoxy-d-Glucose in a Glioblastoma Model
Maja Sołtyka-Krajewska, Marcin Ziemniak, Anna Zawadzka-Kazimierczuk, et al.
Molecular Cancer Therapeutics
|
January 8, 2010
Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway
Jun Wei, Jason Barr, Ling-Yuan Kong, et al.
Plos One
|
September 22, 2011
Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms
Hong Yan, Xin Chen, Qiuping Zhang, et al.
International Journal of Biological Macromolecules
|
April 8, 2026
Computational discovery and preclinical validation of a novel nanodrug eEF2 kinase inhibitor for suppression of tumor growth in triple-negative breast cancer by induction of ferroptosis and apoptosis
Ferah Comert Onder, Nermin Kahraman, Pinar Siyah, et al.
Journal of Neuro-Oncology
|
January 18, 2012
Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway
Ke Sai, Shuzhen Wang, Veerakumar Balasubramaniyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2010
Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model
Ling-Yuan Kong, Alexander Gelbard, Jun Wei, et al.
Neuro-Oncology
|
July 4, 2012
Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma
Tiffany A Doucette, Ling-Yuan Kong, Yuhui Yang, et al.
JCI Insight
|
December 11, 2025
First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patients
Robert C Castellino, Hope L Mumme, Andrea T Franson, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 128) with videos related to
Sort By:
Page
of 13
Journal of Neuroimmunology
|
December 4, 2014
Therapeutic targets in subependymoma
Ling-Yuan Kong, Jun Wei, Ali S Haider, et al.
Biochimica Et Biophysica Acta
|
March 26, 2013
Development of novel molecular probes of the Rio1 atypical protein kinase
Marcin Mielecki, Krzysztof Krawiec, Irene Kiburu, et al.
Biomedicines
|
October 26, 2024
Potent Biological Activity of Fluorinated Derivatives of 2-Deoxy-d-Glucose in a Glioblastoma Model
Maja Sołtyka-Krajewska, Marcin Ziemniak, Anna Zawadzka-Kazimierczuk, et al.
Molecular Cancer Therapeutics
|
January 8, 2010
Glioblastoma cancer-initiating cells inhibit T-cell proliferation and effector responses by the signal transducers and activators of transcription 3 pathway
Jun Wei, Jason Barr, Ling-Yuan Kong, et al.
Plos One
|
September 22, 2011
Drug-tolerant cancer cells show reduced tumor-initiating capacity: depletion of CD44 cells and evidence for epigenetic mechanisms
Hong Yan, Xin Chen, Qiuping Zhang, et al.
International Journal of Biological Macromolecules
|
April 8, 2026
Computational discovery and preclinical validation of a novel nanodrug eEF2 kinase inhibitor for suppression of tumor growth in triple-negative breast cancer by induction of ferroptosis and apoptosis
Ferah Comert Onder, Nermin Kahraman, Pinar Siyah, et al.
Journal of Neuro-Oncology
|
January 18, 2012
Induction of cell-cycle arrest and apoptosis in glioblastoma stem-like cells by WP1193, a novel small molecule inhibitor of the JAK2/STAT3 pathway
Ke Sai, Shuzhen Wang, Veerakumar Balasubramaniyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 15, 2010
Inhibition of p-STAT3 enhances IFN-alpha efficacy against metastatic melanoma in a murine model
Ling-Yuan Kong, Alexander Gelbard, Jun Wei, et al.
Neuro-Oncology
|
July 4, 2012
Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma
Tiffany A Doucette, Ling-Yuan Kong, Yuhui Yang, et al.
JCI Insight
|
December 11, 2025
First-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patients
Robert C Castellino, Hope L Mumme, Andrea T Franson, et al.
Page
of 13